- ASSISTANT PROFESSOR Pediatrics, Newborn Medicine
- ASSISTANT PROFESSOR Preventive Medicine
Neonatal & Perinatal Medicine
American Board of Pediatrics
MD, Harvard Medical School
MPH, Mount Sinai School of Medicine
Mount Sinai Hospital
Mount Sinai Hospital
Dr. Annemarie Stroustrup is a clinician and clinical researcher in the Division of Newborn Medicine. She received her medical degree from Harvard Medical School and the Massachusetts Institute of Technology. She completed both her general pediatric training and her fellowship in neonatology at the Mount Sinai Hospital. She received her master of public health degree from the Mount Sinai School of Medicine. She is an attending physician in the neonatal intensive care unit with joint appointment to both the Departments of Pediatrics and Preventive Medicine.
The Dr. Harold and Golden Lamport Research Award for Clinical Research
Dr. Stroustrup’s research interests span the disciplines of perinatal epidemiology, neonatology, and environmental health. Specifically, she works to better understand modifiable causes of adverse outcomes in neonates born preterm, low birth weight, or otherwise ill. Her current research focuses on elucidating potential environmental contributors to poor neurodevelopmental outcomes in NICU graduates.
Current research support:
NIH/ NIEHS 1K23ES022268-01 (PI: Stroustrup A) 9/3/2013 – 5/31/2018
Chemical Exposures and Infant Outcomes in the Neonatal Intensive Care Unit
Description: In this project we aim to understand the impact of chemical and non-chemical (social, emotional) exposures in the hospital environment on long-term neurodevelopmental outcomes of preterm infants. This work could allow modification of the NICU experience to optimize outcomes for hundreds of thousands of children born preterm each year.
Completed research support (within the past 3 years):
Passport Foundation (PI: Stroustrup A) 12/1/2011 – 12/30/2013
Environmental chemical exposure in the neonatal intensive care unit
Description: In this project we are both assessing very low birth weight infants hospitalized in the neonatal intensive care unit for exposure to industrial chemicals and validating an exposure checklist tool.
Mount Sinai Children’s Environmental Health Center
(PI: Stroustrup A) 7/1/2011-6/30/2013
Hospital-based phthalate exposure in very low birth weight neonates
Description: In this project we are investigating the relationship between phthalate and BPA exposure in the neonatal intensive care unit among very low birth weight infants and clinical outcomes including neurodevelopmental progress, somatic growth, and thyroid function.
NIH KL2RR029885 (PI: Sampson H) 7/1/2010 – 6/30/2012
Identification of early predictors of fetomaternal hemorrhage and development of an automated screening strategy for at-risk pregnancies
Description: In this study we are identifying early clinical predictors of fetomaternal hemorrhage and piloting multiple laboratory testing strategies to identify the disease in the general pregnant population.
Role: KL2 Investigator
NIH L40 HL090239 (PI: Stroustrup A) 7/1/2007-6/30/2009
Epidemiology and management of transient tachypnea of the newborn
Description: In this series of studies, we are investigating the epidemiology and potential novel management strategies for transient tachypnea of the newborn via patient-oriented research and a pilot clinical trial.
Santos J, Pearce SE, Stroustrup A. Impact of hospital-based environmental exposures on neurodevelopmental outcomes of preterm infants. Current opinion in pediatrics 2015 Jan;.
Egbe A, Uppu S, Lee S, Stroustrup A, Ho D, Srivastava S. Congenital Malformations in the Newborn Population: A Population Study and Analysis of the Effect of Gender and Prematurity. Pediatrics and neonatology 2014 Sep;.
Egbe A, Uppu S, Stroustrup A, Lee S, Ho D, Srivastava S. Incidences and sociodemographics of specific congenital heart diseases in the United States of America: an evaluation of hospital discharge diagnoses. Pediatric cardiology 2014 Aug; 35(6).
Pierce LM, Raab EL, Holzman IR, Ginsburg RN, Brodie SE, Stroustrup A. Importance of birth weight as a risk factor for severe retinopathy of prematurity when gestational age is 30 or more weeks. American journal of ophthalmology 2014 Jun; 157(6): 1227-1230.
Egbe A, Uppu S, Lee S, Stroustrup A, Ho D, Srivastava S. Temporal Variation of Birth Prevalence of Congenital Heart Disease in the United States. Congenital heart disease 2014 Feb;.
Stroustrup A, Plafkin C, Savitz DA. Impact of physician awareness on diagnosis of fetomaternal hemorrhage. Neonatology 2014 Feb; 105(4): 250-255.
DeLuca LM, Fox NS, Green RS, Stroustrup A, Harris M, Holzman IR, Gibbs K. Ovulation induction and small for gestational age neonates in twin pregnancies. Journal of neonatal-perinatal medicine 2013; 6(3): 217-224.
Stroustrup A, Weintraub AS, Cadet CT, Perez R, DeLorenzo E, Holzman IR. Group B Streptococcus exposure and self-limited respiratory distress in late preterm and term neonates. Neonatology 2013 Aug; 104(3): 210-215.
Weintraub AS, Cadet CT, Perez R, DeLorenzo E, Holzman IR, Stroustrup A. Antibiotic use in newborns with transient tachypnea of the newborn. Neonatology 2013 Feb; 103(3): 235-240.
Stroustrup A, Trasande L. Demographics, clinical characteristics and outcomes of neonates diagnosed with fetomaternal haemorrhage. Arch Dis Child Fetal Neonatal Ed 2012 Nov;.
Stroustrup A, Trasande L, Holzman I. Randomized Controlled Trial of Restrictive Fluid Management in Transient Tachypnea of the Newborn. J Pediatr 2012 Jan; 160: 38-43.
Stroustrup A, Trasande L. Epidemiological characteristics and resource use in neonates with bronchopulmonary dysplasia: 1993-2006. Pediatrics 2010 Aug; 126(2): 291-297.
Stroustrup A, Kornetsky S, Joffe S. Knowledge of regulations governing pediatric research among members of institutional review boards that evaluate pediatric protocols: a pilot study. IRB 2008; 30(5): 1-7.
Stroustrup Smith A, Levine D, Robertson R, Barnes P. The fetal kinked brainstem: sign of a severely dysgenetic brain. Ultrasound Med 2005; 24: 1697-1709.
He MM, Stroustrup Smith A, Oslob JD, Flanagan WM, Braisted AC, Whitty A, Cancilla MT, Wang J, Lugovskoy AA, Yoburn JC, Fung AD, Farrington G, Eldredge J, Day ES, Cruz LA, Cachero TG, Miller S, Friedman JE, Choong IC, Cunningham BC. Small molecule inhibition of TNF-alpha. Science 2005; 310: 1022-1022.
Stroustrup Smith A, Estroff JA, Barnewolt CE, Mulliken JB, Levine D. Prenatal diagnosis of cleft lip and cleft palate by magnetic resonance imaging: A pictorial essay. Am J Roentgenol 2004; 183: 229-235.
Stroustrup Smith A, Levine D. Appearance of an interhemispheric cyst associated with agenesis of the corpus callosum. Am J Neuroradiol 2004 Jun-Jul; 25: 1037-1040.
Stroustrup Smith A, Grable I, Levine D. Case 66: Caudal regression syndrome in the fetus of a diabetic mother Part II. Radiology 2004 Jan; 230: 229-233.
Stroustrup Smith A, Grable I, Levine D. Case 66: Caudal regression syndrome in the fetus of a diabetic mother, Part I. Radiology 2003; 28: 691-692.
Levine D, Stroustrup Smith A, McKenzie C. Tips and tricks of fetal MR imaging . Radiologic Clinics of North America 2003 Jul; 41: 729-745.
Stroustrup Smith A, Huang W, Wong G, Levine D. Placental chorangiosis associated with markedly elevated maternal chorionic gonadotropin. J Reprod Med 2003 Oct; 48: 827-30.
Forrest SR, Burrows PE, Stroustrup A, Strickland D. Intense second harmonic generation and long range structural ordering in thin films of an organic salt grown by vapor phase deposition. Appl Phys Lett 1996; 68: 1326-1328.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Stroustrup did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Kravis Children Floor 6th Floor Room 336
1184 Fifth Avenue
New York, NY 10029
Klingenstein Pavillion Floor 3 Room NICU
1176 Fifth Avenue
New York, NY 10029